Flublok Now Approved for Use in All Adults

Flublok Now Approved for Use in All Adults
Flublok Now Approved for Use in All Adults

Protein Sciences announced that the Food and Drug Administration has approved Flublok (trivalent recombinant hemagglutinin [rHA] influenza vaccine) for all adults aged 18 and older.

Previously, Flublok was approved for use in adults aged 18–49 for active immunization against influenza virus subtypes A and B. Flublok is a pure influenza vaccine that does not contain egg proteins, preservatives, antibiotics, gelatin, or latex. It contains three times more antigen than traditional flu vaccines.

RELATED: New Flublok Vaccine Strain for 2014/15 Season

Flublok is supplied as 0.5mL single-dose vials in 10-count cartons.

For more information call (888) 855-7871 or visit Flublok.com.

Loading links....